New pharmacological treatment options for chronic constipation

2014 ◽  
Vol 15 (7) ◽  
pp. 927-941 ◽  
Author(s):  
Maura Corsetti ◽  
Jan Tack
2016 ◽  
Vol 15 (8) ◽  
pp. 1041-1054 ◽  
Author(s):  
Alba Velo-García ◽  
Eleana Ntatsaki ◽  
David Isenberg

2016 ◽  
Vol 389 (7) ◽  
pp. 671-694 ◽  
Author(s):  
Gerhard J. Molderings ◽  
Britta Haenisch ◽  
Stefan Brettner ◽  
Jürgen Homann ◽  
Markus Menzen ◽  
...  

2020 ◽  
Vol 2020 ◽  
pp. 1-6
Author(s):  
Abdulaziz Alhossan ◽  
Ziyad Alrabiah ◽  
Sultan M. Alghadeer ◽  
Syed Wajid ◽  
Mohamed N. Al-Arifi ◽  
...  

Background and Aim. Chronic constipation is frequently underreported as people with obstruction do not generally seek medical advice. This study was aimed at determining the prevalence of chronic constipation and assessing satisfaction with current chronic constipation treatment options. Methods. This study was undertaken in Riyadh City, Saudi Arabia, in April 2019. The study population comprised respondents aged ≥18 years who had been recruited to participate through advertising on social media. Results. Of 532 respondents who completed our questionnaire, 153 (25.4%) had constipation, based on listed criteria, and of these, 121 (22.7%) reported having been constipated for ≥6 months; nearly 48% reported having been constipated for >3 years, while 63.6% of those chronically constipated were female. Bisacodyl was the laxative medication most used to treat chronic constipation, and 17.4% of users reported that they had used laxative medication for >12 months. Complementary and alternative medicines (CAMs) were utilized in 44.4% of respondents with chronic constipation. There was a significant association between the group who used CAMs and age (p=0.013). Drinking water was the most common CAM adopted for those experiencing chronic constipation, followed by consumption of fiber (35.5%) and senna (19.8%).


2016 ◽  
Vol 33 (S1) ◽  
pp. S432-S432
Author(s):  
B. Sánchez Sánchez ◽  
P. Muñoz-Calero Franco ◽  
N. Rodriguez Criado ◽  
J.F. Cruz Fourcade ◽  
R. Martín Aragón ◽  
...  

IntroductionAnorexia nervosa is a disorder of eating behavior that is a major health problem on our society. It is characterized by three main criteria: self-induced starvation, desire for thinness or fear of obesity, and the presence of medical signs and symptoms due to improper feeding. This work is focused on its treatment. The biopsychosocial approach allows the design and application of effective therapeutic strategies and a multidisciplinary team collaboration is essential.ObjectivesResearch of current pharmacological and psychotherapy treatments options of the disease.Material and methodsLiterature review based on articles and publications on this topic.ResultsIn anorexia nervosa, it is necessary to establish a therapeutic alliance between doctor and patient. Patient usually feels no motivation to improve. The different treatments options to combine, in terms of the patient status, are: nutritional rehabilitation, cognitive-behavioral, family and interpersonal psychotherapies and pharmacological treatment. It can be carried out at the ambulatory, at the day-hospital or by medical stay, even beyond patient will.ConclusionsNowadays, the nutritional rehabilitation is the best treatment established and it is the core treatment. About the psychotherapies, the cognitive-behavioral is the most used because it has exposed better results in all different studies proved and in clinical practices, followed by the family therapy which is the responsible of the patient family's treatment. Pharmacological treatment should not be used systematically and its exclusive use is not enough to resolve anorexia nervosa as there are needed also other treatments combined.Disclosure of interestThe authors have not supplied their declaration of competing interest.


Sign in / Sign up

Export Citation Format

Share Document